As we have seen in the first article of our series, trademarks play an important role in the protection of your pharmaceutical and life science products and can add significant value. But to understand the benefits but also...more
Dear Readers, We are pleased to introduce an innovation in this issue of TRADEMARK INSIGHT: In response to many suggestions, in each issue, after the usual summaries of German and European trademark case law, we will put a...more
Liebe Leserinnen und Leser, wir freuen uns, Ihnen mit dieser Ausgabe des TRADEMARK INSIGHT eine Neuerung vorzustellen: Auf vielfache Anregung werden wir künftig jeweils in einer neuen Rubrik (Country Focus) nach den...more
The Italian Patent and Trademark Office issued a Decree providing for a stay of all official deadlines falling within 9 March and 3 April 2020....more
This month, the Court of Justice of the European Union (CJEU) addressed a case of particular interest for pharmaceutical companies that are in the process of developing a new product. Regulatory and commercial considerations...more
7/19/2019
/ Advertising ,
Appeals ,
Clinical Trials ,
Court of Justice of the European Union (CJEU) ,
General Court of the European Union (GCEU) ,
Intellectual Property Protection ,
Marketing Perspectives ,
Non-Use of Trademarks ,
Pharmaceutical Industry ,
Regulatory Standards ,
Revocation ,
Trademarks